17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome

Pia Bernardo, Francesca Madia, Lia Santulli, Luigi Del Gaudio, Carmela Caccavale, Federico Zara, Monica Traverso, Mario Cirillo, Salvatore Striano, Antonietta Coppola

Research output: Contribution to journalArticle

Abstract

The widespread use of Array Comparative Genomic Hybridization (aCGH) technology has enabled the identification of several syndromes associated with copy number variants (CNVs) including the 17q21.31 microdeletion. The 17q21.31 microdeletion syndrome, also known as Koolen-de Vries syndrome, was first described in 2006 in individuals with intellectual disabilities and organ abnormalities.We report the clinical, instrumental, cytogenetic and molecular investigations of a boy admitted for epilepsy and intellectual disabilities. We carried out detailed analysis of the clinical phenotype of this patient and investigated the genetic basis by using aCGH. We identified a de novo microdeletion on chromosome 17q21.31, compatible with Koolen-de Vries syndrome.Our case shares some of the typical characteristics of the syndrome already described by other authors: delayed psychomotor development, primarily affecting the expressive language, dysmorphic facial features, and epilepsy. However the clinical outcome was not severe as the intellectual disabilities were moderate with good adaptive and functional behaviour. Epilepsy was easily controlled by a single drug, and he never needed surgery for organ abnormalities.

Original languageEnglish
JournalBrain and Development
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Intellectual Disability
Epilepsy
Comparative Genomic Hybridization
Psychological Adaptation
Cytogenetics
Language
Chromosomes
Technology
Phenotype
Pharmaceutical Preparations
Chromosome 17q21.31 Deletion Syndrome

Keywords

  • 17q21.31 microdeletion
  • Array-CGH
  • Behavioural disorders
  • Copy number variation
  • Epilepsy
  • Intellectual disability

ASJC Scopus subject areas

  • Clinical Neurology
  • Developmental Neuroscience
  • Pediatrics, Perinatology, and Child Health

Cite this

17q21.31 microdeletion syndrome : Description of a case further contributing to the delineation of Koolen-de Vries syndrome. / Bernardo, Pia; Madia, Francesca; Santulli, Lia; Del Gaudio, Luigi; Caccavale, Carmela; Zara, Federico; Traverso, Monica; Cirillo, Mario; Striano, Salvatore; Coppola, Antonietta.

In: Brain and Development, 2016.

Research output: Contribution to journalArticle

Bernardo, Pia ; Madia, Francesca ; Santulli, Lia ; Del Gaudio, Luigi ; Caccavale, Carmela ; Zara, Federico ; Traverso, Monica ; Cirillo, Mario ; Striano, Salvatore ; Coppola, Antonietta. / 17q21.31 microdeletion syndrome : Description of a case further contributing to the delineation of Koolen-de Vries syndrome. In: Brain and Development. 2016.
@article{7b20026011114365a6068e59a0f6998c,
title = "17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome",
abstract = "The widespread use of Array Comparative Genomic Hybridization (aCGH) technology has enabled the identification of several syndromes associated with copy number variants (CNVs) including the 17q21.31 microdeletion. The 17q21.31 microdeletion syndrome, also known as Koolen-de Vries syndrome, was first described in 2006 in individuals with intellectual disabilities and organ abnormalities.We report the clinical, instrumental, cytogenetic and molecular investigations of a boy admitted for epilepsy and intellectual disabilities. We carried out detailed analysis of the clinical phenotype of this patient and investigated the genetic basis by using aCGH. We identified a de novo microdeletion on chromosome 17q21.31, compatible with Koolen-de Vries syndrome.Our case shares some of the typical characteristics of the syndrome already described by other authors: delayed psychomotor development, primarily affecting the expressive language, dysmorphic facial features, and epilepsy. However the clinical outcome was not severe as the intellectual disabilities were moderate with good adaptive and functional behaviour. Epilepsy was easily controlled by a single drug, and he never needed surgery for organ abnormalities.",
keywords = "17q21.31 microdeletion, Array-CGH, Behavioural disorders, Copy number variation, Epilepsy, Intellectual disability",
author = "Pia Bernardo and Francesca Madia and Lia Santulli and {Del Gaudio}, Luigi and Carmela Caccavale and Federico Zara and Monica Traverso and Mario Cirillo and Salvatore Striano and Antonietta Coppola",
year = "2016",
doi = "10.1016/j.braindev.2016.02.002",
language = "English",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",

}

TY - JOUR

T1 - 17q21.31 microdeletion syndrome

T2 - Description of a case further contributing to the delineation of Koolen-de Vries syndrome

AU - Bernardo, Pia

AU - Madia, Francesca

AU - Santulli, Lia

AU - Del Gaudio, Luigi

AU - Caccavale, Carmela

AU - Zara, Federico

AU - Traverso, Monica

AU - Cirillo, Mario

AU - Striano, Salvatore

AU - Coppola, Antonietta

PY - 2016

Y1 - 2016

N2 - The widespread use of Array Comparative Genomic Hybridization (aCGH) technology has enabled the identification of several syndromes associated with copy number variants (CNVs) including the 17q21.31 microdeletion. The 17q21.31 microdeletion syndrome, also known as Koolen-de Vries syndrome, was first described in 2006 in individuals with intellectual disabilities and organ abnormalities.We report the clinical, instrumental, cytogenetic and molecular investigations of a boy admitted for epilepsy and intellectual disabilities. We carried out detailed analysis of the clinical phenotype of this patient and investigated the genetic basis by using aCGH. We identified a de novo microdeletion on chromosome 17q21.31, compatible with Koolen-de Vries syndrome.Our case shares some of the typical characteristics of the syndrome already described by other authors: delayed psychomotor development, primarily affecting the expressive language, dysmorphic facial features, and epilepsy. However the clinical outcome was not severe as the intellectual disabilities were moderate with good adaptive and functional behaviour. Epilepsy was easily controlled by a single drug, and he never needed surgery for organ abnormalities.

AB - The widespread use of Array Comparative Genomic Hybridization (aCGH) technology has enabled the identification of several syndromes associated with copy number variants (CNVs) including the 17q21.31 microdeletion. The 17q21.31 microdeletion syndrome, also known as Koolen-de Vries syndrome, was first described in 2006 in individuals with intellectual disabilities and organ abnormalities.We report the clinical, instrumental, cytogenetic and molecular investigations of a boy admitted for epilepsy and intellectual disabilities. We carried out detailed analysis of the clinical phenotype of this patient and investigated the genetic basis by using aCGH. We identified a de novo microdeletion on chromosome 17q21.31, compatible with Koolen-de Vries syndrome.Our case shares some of the typical characteristics of the syndrome already described by other authors: delayed psychomotor development, primarily affecting the expressive language, dysmorphic facial features, and epilepsy. However the clinical outcome was not severe as the intellectual disabilities were moderate with good adaptive and functional behaviour. Epilepsy was easily controlled by a single drug, and he never needed surgery for organ abnormalities.

KW - 17q21.31 microdeletion

KW - Array-CGH

KW - Behavioural disorders

KW - Copy number variation

KW - Epilepsy

KW - Intellectual disability

UR - http://www.scopus.com/inward/record.url?scp=84958214719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958214719&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2016.02.002

DO - 10.1016/j.braindev.2016.02.002

M3 - Article

AN - SCOPUS:84958214719

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

ER -